ISL
SRTS icon

Ingalls & Snyder LLC’s Sensus Healthcare SRTS Stock Holding History

Ingalls & Snyder LLC’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Hold
55,000
– – ﹤0.01% 445
2026
Q1 		$219K Hold
55,000
– – 0.01% 417
2025
Q4 		$219K Buy
+55,000
New +$204K 0.01% 430

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Ingalls & Snyder LLC's SRTS Position: Q2 2026 in Review

Ingalls & Snyder LLC held its Sensus Healthcare (SRTS) position steady in Q2 2026 at 55,000 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Ingalls & Snyder LLC first reported a position in SRTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $219K in Q1 2026. 38 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.

  • Ingalls & Snyder LLC held 55,000 shares of Sensus Healthcare worth $166K as of Q2 2026.
  • Ingalls & Snyder LLC left its Sensus Healthcare share count unchanged in Q2 2026.
  • Sensus Healthcare made up ﹤0.01% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #445 holding.
  • Ingalls & Snyder LLC first reported a position in Sensus Healthcare in Q4 2025 and has held it in 3 quarters since.
  • Ingalls & Snyder LLC's Sensus Healthcare position peaked at $219K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.